Cadenza Bio
About:
Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules.
Website: https://www.cadenza.bio
Top Investors: Cortado Ventures, Illinois Ventures, Boyd Street Ventures, Plains Ventures, Oklahoma Life Science Fund
Description:
Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules. We are committed to developing therapeutic medications that will improve the lives of patients suffering from terrible diseases.
Total Funding Amount:
$2.44M
Headquarters Location:
Oklahoma City, Oklahoma, United States
Founded Date:
2022-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-12-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai